Literature DB >> 17376385

The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.

Sheldon P Stone1, Ben S Cooper, Chris C Kibbler, Barry D Cookson, Jenny A Roberts, Graham F Medley, Georgia Duckworth, Rosalind Lai, Shah Ebrahim, Erwin M Brown, Phil J Wiffen, Peter G Davey.   

Abstract

The quality of research in hospital epidemiology (infection control) must be improved to be robust enough to influence policy and practice. In order to raise the standards of research and publication, a CONSORT equivalent for these largely quasi-experimental studies has been prepared by the authors of two relevant systematic reviews, following consultation with learned societies, editors of journals, and researchers. The ORION (Outbreak Reports and Intervention Studies Of Nosocomial infection) statement consists of a 22 item checklist, and a summary table. The emphasis is on transparency to improve the quality of reporting and on the use of appropriate statistical techniques. The statement has been endorsed by a number of professional special interest groups and societies. Like CONSORT, ORION should be considered a "work in progress", which requires ongoing dialogue for successful promotion and dissemination. The statement is therefore offered for further public discussion. Journals and research councils are strongly recommended to incorporate it into their submission and reviewing processes. Feedback to the authors is encouraged and the statement will be revised in 2 years.

Entities:  

Mesh:

Year:  2007        PMID: 17376385     DOI: 10.1016/S1473-3099(07)70082-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  68 in total

Review 1.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

2.  Patient care experience with utilization of isolation precautions: systematic literature review and meta-analysis.

Authors:  R Nair; E N Perencevich; M Goto; D J Livorsi; E Balkenende; E Kiscaden; M L Schweizer
Journal:  Clin Microbiol Infect       Date:  2020-01-30       Impact factor: 8.067

3.  Global avian influenza outbreaks 2010-2016: a systematic review of their distribution, avian species and virus subtype.

Authors:  Ioanna P Chatziprodromidou; Malamatenia Arvanitidou; Javier Guitian; Thomas Apostolou; George Vantarakis; Apostolos Vantarakis
Journal:  Syst Rev       Date:  2018-01-25

4.  Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Authors:  Kenneth M Wener; Vered Schechner; Howard S Gold; Sharon B Wright; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

5.  Editorial: the art of scientific publication.

Authors:  Jennie Wilson
Journal:  J Infect Prev       Date:  2015-10-27

6.  Outbreak reporting guide.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2015-04-02

7.  [Nosocomial infections. Evidence based infection control measures].

Authors:  P Gastmeier
Journal:  Internist (Berl)       Date:  2010-02       Impact factor: 0.743

Review 8.  Infection control for norovirus.

Authors:  L Barclay; G W Park; E Vega; A Hall; U Parashar; J Vinjé; B Lopman
Journal:  Clin Microbiol Infect       Date:  2014-07-16       Impact factor: 8.067

9.  Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome.

Authors:  Simone Lanini; Isabella Abbate; Vincenzo Puro; Fabrizio Soscia; Franceso Albertoni; Walter Battisti; Amilacare Ruta; Maria R Capobianchi; Giuseppe Ippolito
Journal:  BMC Infect Dis       Date:  2010-08-27       Impact factor: 3.090

Review 10.  Emerging technologies for HIV prevention for MSM: what we have learned, and ways forward.

Authors:  Patrick S Sullivan; Jeremy A Grey; Brian R Simon Rosser
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.